Will Emerging Markets Outperform the US in 2020?

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – Today’s featured article examines whether or not emerging markets will outperform the U.S. in 2020. Continue reading for all these important investor details.

U.S stocks are enjoying an unprecedented outperformance over emerging markets. Can it continue, or is now the time to rotate money overseas?  There is beginning to be the belief that if the trade tensions get resolved, and tariffs removed, it will renew global growth of which the biggest beneficiaries would be emerging markets. 

Historically when stocks are in bull mode, bullish money managers will take on more speculative positions such as higher beta names, including increasing exposure to emerging markets.  On the other hand, investors are positioning themselves for lower stock prices, riskier assets such as emerging market stocks tend to underperform, particularly relative to developed markets.

You can see the relative performance from two prior periods in which after the S&P makes a new low, but then emerging market then goes on to outperform the U.S. 

emerging markets news

emerging markets

emerging markets

Essentially, when the S&P 500 is making lower lows but Emerging Markets are simultaneously making higher lows, it’s been evidence of risk appetite for stocks and markets have continued to rally for years after the divergence. But, what we have seen over the past year is not quite following the pattern. 

You can see the extreme decoupling that occurred between the S&P 500 Index (blue line) and Emerging Market Index (EEM) that began in May, but then the sell-off last fall was far steeper in U.S. stocks, causing a brief convergence in performance.   

Like past patterns, emerging markets did not make a new low, which would suggest that when the U.S. rebounded emerging markets would outperform. 

But instead, the recent rebound has sent U.S. stocks sprinting away and well ahead of emerging markets. 

eem ishares

One difference from prior periods is that through it’s growing economy, China now represents over 35% of the emerging market index, and it’s stock market has done very poorly, dropping some 30% over the past six months and not showing much of a rebound of late, which creates a big drag on the overall index. 

It appears that negative sentiment may overshoot, as emerging markets currencies have sold off by more than debt and equity outflows would generally imply. 

On the other side of the coin, the flows into emerging market equities recorded outflows from June through November but turned positive in January. 

Emerging markets equities now have the lowest valuations of any major asset class and free cash flow yields estimated at 5%–7% over the next 12–15 months. Their discount to developed markets has deepened to the 30% range.  

Some individual emerging markets, bottomed before the U.S. and are enjoying a bigger rebound. 

For example, Brazil is some 45% since the October low, well ahead of the S&P 500’s 20% rebound from it’s December low. 

ewz markets

If we resume historical patterns, I would expect other emerging markets, from India and eventually China, to begin outperforming the U.S. 


SPY shares were trading at $319.74 per share on Tuesday morning, up $0.24 (+0.08%). Year-to-date, SPY has gained 29.72%, versus a 29.72% rise in the benchmark S&P 500 index during the same period.


About the Author: Option Sensei


Steve has more than 30 years of investment experience with an expertise in options trading. He’s written for TheStreet.com, Minyanville and currently for Option Sensei. Learn more about Steve’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Expert Predicts 3-6 Months of Pain

2 important market developments are leading market expert Steve Reitmeister to predict 3 to 6 months of painful market conditions pushing the S&P 500 (SPY) lower. Read on for the full story...

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more...

3 Tech Stocks Analysts Say Are "Strong Buys" for 2025

The technology industry is well-positioned for significant growth thanks to the rapid advancements in emerging technologies and the digitization of business operations. Amid this backdrop, fundamentally solid tech stocks Adobe (ADBE), Leidos Holdings (LDOS), and DocuSign (DOCU) could be strong buys for 2025. Continue reading...

3 Tech Stocks Under $20 With Breakout Potential

The tech sector is the core of innovation, from transforming industries to powering economic progress. Amid this backdrop, investors could consider buying sound under $20 tech stocks Vimeo (VMEO), PubMatic (PUBM), and Eventbrite (EB). Keep reading…

How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News